Sequencing Sacituzumab Govitecan (SG) AfteR Trastuzumab Deruxtecan (T-DXd) In ER+/HER2 LOW MetaStatic Breast Cancer
Publication Date
12-10-2024
Presented At:
San Antonio Breast Cancer Symposium (SABCS)
Citation
Mahtani, Reshma; Sandoval Leon, Ana Cristina; Abreu, Maria; and Ahluwalia, Manmeet, "Sequencing Sacituzumab Govitecan (SG) AfteR Trastuzumab Deruxtecan (T-DXd) In ER+/HER2 LOW MetaStatic Breast Cancer" (2024). All Publications. 5488.
https://scholarlycommons.baptisthealth.net/se-all-publications/5488